IBDEI0OO ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11765,2)
 ;;=^331857
 ;;^UTILITY(U,$J,358.3,11766,0)
 ;;=295.90^^53^673^13
 ;;^UTILITY(U,$J,358.3,11766,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11766,1,2,0)
 ;;=2^295.90
 ;;^UTILITY(U,$J,358.3,11766,1,5,0)
 ;;=5^Schizophrenia NOS,Unspec
 ;;^UTILITY(U,$J,358.3,11766,2)
 ;;=^108287
 ;;^UTILITY(U,$J,358.3,11767,0)
 ;;=300.11^^53^674^1
 ;;^UTILITY(U,$J,358.3,11767,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11767,1,2,0)
 ;;=2^300.11
 ;;^UTILITY(U,$J,358.3,11767,1,5,0)
 ;;=5^Conversion Disorder
 ;;^UTILITY(U,$J,358.3,11767,2)
 ;;=^28139
 ;;^UTILITY(U,$J,358.3,11768,0)
 ;;=300.7^^53^674^2
 ;;^UTILITY(U,$J,358.3,11768,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11768,1,2,0)
 ;;=2^300.7
 ;;^UTILITY(U,$J,358.3,11768,1,5,0)
 ;;=5^Hyponchondriasis
 ;;^UTILITY(U,$J,358.3,11768,2)
 ;;=^60556
 ;;^UTILITY(U,$J,358.3,11769,0)
 ;;=300.81^^53^674^3
 ;;^UTILITY(U,$J,358.3,11769,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11769,1,2,0)
 ;;=2^300.81
 ;;^UTILITY(U,$J,358.3,11769,1,5,0)
 ;;=5^Somatization Disorder
 ;;^UTILITY(U,$J,358.3,11769,2)
 ;;=^112280
 ;;^UTILITY(U,$J,358.3,11770,0)
 ;;=307.1^^53^675^1
 ;;^UTILITY(U,$J,358.3,11770,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11770,1,2,0)
 ;;=2^307.1
 ;;^UTILITY(U,$J,358.3,11770,1,5,0)
 ;;=5^Anorexia Nervosa
 ;;^UTILITY(U,$J,358.3,11770,2)
 ;;=^7942
 ;;^UTILITY(U,$J,358.3,11771,0)
 ;;=307.51^^53^675^2
 ;;^UTILITY(U,$J,358.3,11771,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11771,1,2,0)
 ;;=2^307.51
 ;;^UTILITY(U,$J,358.3,11771,1,5,0)
 ;;=5^Bulemia Nervosa
 ;;^UTILITY(U,$J,358.3,11771,2)
 ;;=^17407
 ;;^UTILITY(U,$J,358.3,11772,0)
 ;;=307.50^^53^675^3
 ;;^UTILITY(U,$J,358.3,11772,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11772,1,2,0)
 ;;=2^307.50
 ;;^UTILITY(U,$J,358.3,11772,1,5,0)
 ;;=5^Eating Disorder, NOS
 ;;^UTILITY(U,$J,358.3,11772,2)
 ;;=^37864
 ;;^UTILITY(U,$J,358.3,11773,0)
 ;;=333.99^^53^676^2
 ;;^UTILITY(U,$J,358.3,11773,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11773,1,2,0)
 ;;=2^333.99
 ;;^UTILITY(U,$J,358.3,11773,1,5,0)
 ;;=5^Acute Akathisia
 ;;^UTILITY(U,$J,358.3,11773,2)
 ;;=^303698
 ;;^UTILITY(U,$J,358.3,11774,0)
 ;;=332.0^^53^676^3
 ;;^UTILITY(U,$J,358.3,11774,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11774,1,2,0)
 ;;=2^332.0
 ;;^UTILITY(U,$J,358.3,11774,1,5,0)
 ;;=5^Parkinsonism
 ;;^UTILITY(U,$J,358.3,11774,2)
 ;;=^304847
 ;;^UTILITY(U,$J,358.3,11775,0)
 ;;=333.79^^53^676^1
 ;;^UTILITY(U,$J,358.3,11775,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11775,1,2,0)
 ;;=2^333.79
 ;;^UTILITY(U,$J,358.3,11775,1,5,0)
 ;;=5^Acquired Torsion Dystonia NEC
 ;;^UTILITY(U,$J,358.3,11775,2)
 ;;=^334068
 ;;^UTILITY(U,$J,358.3,11776,0)
 ;;=333.85^^53^676^4
 ;;^UTILITY(U,$J,358.3,11776,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11776,1,2,0)
 ;;=2^333.85
 ;;^UTILITY(U,$J,358.3,11776,1,5,0)
 ;;=5^Tardive Dyskinesia
 ;;^UTILITY(U,$J,358.3,11776,2)
 ;;=^334069
 ;;^UTILITY(U,$J,358.3,11777,0)
 ;;=V87.39^^53^677^1
 ;;^UTILITY(U,$J,358.3,11777,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11777,1,2,0)
 ;;=2^V87.39
 ;;^UTILITY(U,$J,358.3,11777,1,5,0)
 ;;=5^Cont/Exp Hazard Sub NEC
 ;;^UTILITY(U,$J,358.3,11777,2)
 ;;=^336815
 ;;^UTILITY(U,$J,358.3,11778,0)
 ;;=310.0^^53^678^1
 ;;^UTILITY(U,$J,358.3,11778,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11778,1,2,0)
 ;;=2^310.0
 ;;^UTILITY(U,$J,358.3,11778,1,5,0)
 ;;=5^Frontal Lobe Syndrome
 ;;^UTILITY(U,$J,358.3,11778,2)
 ;;=^265201
 ;;^UTILITY(U,$J,358.3,11779,0)
 ;;=310.1^^53^678^3
 ;;^UTILITY(U,$J,358.3,11779,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11779,1,2,0)
 ;;=2^310.1
 ;;^UTILITY(U,$J,358.3,11779,1,5,0)
 ;;=5^Personality Chg d/t TBI/Lesion
 ;;
 ;;$END ROU IBDEI0OO
